Skip to main content
Premium Trial:

Request an Annual Quote

Pronota, Cedars-Sinai Medical Center

Premium
Pronota this week launched the MASSterclass platform for biomarker verification. The platform incorporates a novel series of orthogonal complexity reduction combined with targeted mass spectrometry. Throughput is maintained when screening large panels of biomarker candidates by multiplexing different analytes in the same assay, the company said in a statement. MASSterclass complements Pronota’s MASStermind biomarker discovery platform.
 

 
Cedars-Sinai Medical Center recently launched ProteoWizard, a modular set of open-source, cross-platform tools and software libraries for proteomics data analysis.
 
Modules include msconvert, a general data format conversion tool; msdiff, a tool for comparing two data files; and msaccess, which provides command-line access to mass spec data files, including spectrum binary data and metadata, selected ion chromatograms, and pseudo-2D gel image creation.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.